Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease Gelon PA, Dutchak PA and Sephton CF (2022)  Front. Mol. Neurosci. 15:1000183. doi: 10.3389/fnmol.2022.1000183

NPRL2 Inhibition of mTORC1 Controls Sodium Channel Expression and Brain Amino Acid Homeostasis. Jeremy B. Hui, Jose Cesar Hernandez Silva, Mari Carmen Pelaez, Myriam Sévigny, Janani Priya Venkatasubramani, Quentin Plumereau, Mohamed Chahine, Christophe D. Proulx, Chantelle F. Sephton and Paul A. Dutchak.  eNeuro. 14 February 2022, ENEURO.0317-21.2022; DOI: https://doi.org/10.1523/ENEURO.0317-21.2022

A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics. Gaël Nicolas, Myriam Sévigny, François Lecoquierre, Florent Marguet, Andréanne Deschênes, Maria Carment del Pelaez, Sébastien Feuillette, Anaïs Audebrand, Magalie Lecourtois, Stéphane Rousseau, Anne-Claire Richard, Kévin Cassinari, Vincent Deramecourt, Charles Duyckaerts, Anne Boland, Jean-François Deleuze, Vincent Meyer, Jordi Clarimon Echavarria, Ellen Gelpi, Haruhiko Akiyama, Masato Hasegawa, Ito Kawakami, Tsz H. Wong, Jeroen G. J. Van Rooij, John C. Van Swieten, Dominique Campion, Paul A. Dutchak, David Wallon, Flavie Lavoie-Cardinal, Annie Laquerrière, Anne Rovelet-Lecrux & Chantelle F. Sephton.  Acta Neuropathol Commun 10, 20 (2022).

Antisense oligonucleotide-based therapeutic strategy for progranulin-deficient frontotemporal dementia Geetika Aggarwal, Subhashis Banerjee, Spencer A. Jones, Monica Pavlack, Yousri Benchaar, Jasmine Bélanger, Myriam Sévigny, Denise M. Smith, Michael L. Niehoff, Ian Mitchelle S. de Vera, Terri L. Petkau, Blair R. Leavitt, Karen Ling, Paymaan Jafar-Nejad, Frank Rigo, John E. Morley, Susan A. Farr, Paul A. Dutchak, Chantelle F. Sephton, Andrew D. Nguyen (2022) BioRxiv doi:10.1101/2022.01.12.476053

FUS contributes to mTOR-dependent inhibition of translation M Sévigny, IB Julien, JP Venkatasubramani, JB Hui, PA Dutchak, CF Sephton (2020) Journal of Biological Chemistry 295 (52), 18459-18473

Metabolic Networks Influencing Skeletal Muscle Fiber Composition. Bourdeau Julien I, Sephton CF, Dutchak PA. (2018) Front. Cell Dev. Biol. 6:125. doi:10.3389/fcell.2018.00125

Loss of a Negative Regulator of mTORC1 Induces Aerobic Glycolysis and Altered Fiber Composition in Skeletal Muscle. Dutchak PA, Estill-Terpack SJ, Plec AA, ... Deberardinis RJ, Yu Y, Tu BP. Cell Rep. 2018 May 15, 23(7): 1907–1914. doi: 10.1016/j.celrep.2018.04.058

Altering cellular differentiation and energy metabolism by the mTORC1 inhibitor NPRL2. Dutchak PA, Estill SJ, Tu BP. Mol Cancer Res April 1 2016 (14) doi:10.1158/1557-3125.DEVBIOLCA15-B08

Regulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2. Dutchak PA, Laxman S, Estill SJ, Wang C, Wang Y, Wang Y, Bulut GB, Gao J, Huang LJ, Tu BP. Cell Rep. 2015 Jul 21;12(3):371-9. doi:10.1016/j.celrep.2015.06.042. Epub 2015 Jul 9. PMID:26166573

Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Dutchak PA, Katafuchi T, Bookout AL, Choi JH, Yu RT, Mangelsdorf DJ, Kliewer SA. Cell. 2012 Feb 3;148(3):556-67. doi:10.1016/j.cell.2011.11.062. PMID:22304921

Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Wei W, Dutchak PA, Wang X, Ding X, Wang X, Bookout AL, Goetz R, Mohammadi M, Gerard RD, Dechow PC, Mangelsdorf DJ, Kliewer SA, Wan Y. Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3143-8. doi: 10.1073/pnas.1200797109. Epub 2012 Feb 6. PMID:22315431

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, Li Y, Goetz R, Mohammadi M, Esser V, Elmquist JK, Gerard RD, Burgess SC, Hammer RE, Mangelsdorf DJ, Kliewer SA. Cell Metab. 2007 Jun;5(6):415-25.PMID:17550777